Literature DB >> 9112428

Immunophenotypic analysis of T-cell acute lymphoblastic leukaemia in Madras, India.

K R Rajalekshmy1, A R Abitha, R Pramila, T Gnanasagar, V Shanta.   

Abstract

Immunophenotypic analysis of 285 newly diagnosed previously untreated, unselected, acute lymphoblastic leukaemia cases carried out at the Cancer Institute (W.I.A) in Madras reveals that 126 (44.2%) cases showed T-immunophenotype. The study was conducted using flow-cytometric immunofluorescent or immunoperoxidase methods using an extensive panel of monoclonal antibodies comprising CD1, 2, 3, 4, 5, 7, 8, 57, 19, 20 kappa, lambda, IgG, M, D, CIg, CD10, HLA-DR, CD13, 14, 33, 34 and CD61. The study group comprised 73 (57.9%) paediatric cases (<15 years) and 53 (42.1%) adult cases (>15 years). Based on their reactivity with various anti-T-cell monoclonal antibodies, all T-ALL cases were assigned to one of the intrathymic differentiation compartments. 56.2% of paediatric T-ALLs arise from intrathymic compartment II, 34.2% from compartment III and 9.6% from compartment I. Among adults, 45.3% arise from compartment I. 33.9% from compartment III and 20.8% from compartment II. The most frequently observed CD antigens in our study group are CD7, 5, 2 and 3. A correlative study of socioeconomic status reveals that 67.5% of T-ALL cases occurred among lower socioeconomic strata.

Entities:  

Mesh:

Year:  1997        PMID: 9112428     DOI: 10.1016/s0145-2126(96)00092-6

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Lympho-hemopoietic malignancies in India.

Authors:  Manisha Bhutani; Amish Vora; Lalit Kumar; Vinod Kochupillai
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

2.  Analysis of outcomes and prognostic factors of acute lymphoblastic leukemia patients treated by MCP841 protocol: A regional cancer center experience.

Authors:  Akhil Kapoor; Ashok Kalwar; Narender Kumar; Mukesh Kumar Singhal; Surender Beniwal; Harvindra Singh Kumar
Journal:  J Res Med Sci       Date:  2016-03-15       Impact factor: 1.852

3.  Acute lymphoblastic leukemia: A single center experience with Berlin, Frankfurt, and Munster-95 protocol.

Authors:  Venkatraman Radhakrishnan; Sumant Gupta; Prasanth Ganesan; Rejiv Rajendranath; Trivadi S Ganesan; Kamalalayan Raghavan Rajalekshmy; Tenali Gnana Sagar
Journal:  Indian J Med Paediatr Oncol       Date:  2015 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.